LaVallee, Theresa M <br/><br/>
Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.  [electronic resource] 

 -  Molecular cancer therapeutics  Jun 2008 
 - 1472-82 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-08-0107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Methoxyestradiol<br/>Administration, Oral<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Binding, Competitive--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colchicine--pharmacology<br/>Drug Screening Assays, Antitumor<br/>Estradiol--analogs & derivatives<br/>Estrenes--administration & dosage<br/>G2 Phase--drug effects<br/>Hepatocytes--drug effects<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Inhibitory Concentration 50<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Microtubules--drug effects<br/>Mitosis--drug effects<br/>Rats<br/>Survival Analysis<br/>Tubulin--metabolism<br/>Tubulin Modulators--administration & dosage